Bell Investment Advisors, Inc

Position in NBIX — Neurocrine Biosciences Inc

CIK 1890149 ORINDA, CA

Position in NBIX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$6,910

-$1,916 QoQ

Shares Held

-38.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#699

of 773 holders

Holding Since

Sep 2021

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bell Investment Advisors, Inc holds $111,986 across 20 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	41	$22,215
2	RDY	Dr Reddys Laboratories Ltd	1,005	$14,562
3	HCM	HUTCHMED (China) Ltd	1,015	$10,921
4	TAK	Takeda Pharmaceutical Co Ltd	488	$7,822
5	VTRS	Viatris Inc	454	$7,209
6	NBIX	Neurocrine Biosciences Inc This page	41	$6,910
7	ZTS	Zoetis Inc.	94	$6,754
8	ELAN	Elanco Animal Health Inc	264	$6,497

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,910	41	-38.8%	Shares	Sole	2026-08-07
2026-03-31	$8,826	67	+76.3%	Shares	Sole	2026-04-17
2025-12-31	$5,389	38	-9.5%	Shares	Sole	2026-02-24
2025-09-30	$5,895	42	-10.6%	Shares	Sole	2025-11-21
2025-06-30	$5,907	47	+56.7%	Shares	Sole	2025-08-11
2025-03-31	$3,318	30	0.0%	Shares	Sole	2025-05-16
2024-12-31	$4,095	30	+42.9%	Shares	Sole	2025-02-07
2024-09-30	$2,419	21	0.0%	Shares	Sole	2024-11-13
2024-06-30	$2,891	21	0.0%	Shares	Sole	2024-08-08
2024-03-31	$2,896	21	0.0%	Shares	Sole	2024-05-08
2023-12-31	$2,766	21	-30.0%	Shares	Sole	2024-02-14
2023-09-30	$3,375	30	-11.8%	Shares	Sole	2023-11-08
2023-06-30	$3,206	34	-12.8%	Shares	Sole	2023-08-09
2023-03-31	$3,947	39	+14.7%	Shares	Sole	2023-05-10
2022-12-31	$4,060	34	+13.3%	Shares	Sole	2023-02-09
2022-09-30	$3,186	30	0.0%	Shares	Sole	2022-11-09
2022-06-30	$2,924	30	+57.9%	Shares	Sole	2022-08-12
2021-09-30	$1,822	19	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.